INTENSIVE CARE MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2219282, encodeId=846f221928247, content=审稿速度:1.0 经验分享：投了一篇Corrrspondence，修稿2次，2个半月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Fri Aug 09 16:30:53 CST 2024, time=2024-08-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=578810, encodeId=54dd5e881084, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589199, encodeId=a19c589199f6, content=请问这个杂志好投吗？medcardio 2015-03-09 12:04:00 发表: 祝贺！, beContent=medcardio 2015-03-09 12:04:00 发表: 祝贺！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70791714941, createdName=执着与奋斗, createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470172, encodeId=f3d64e0172ab, content=重视偏重系列研究的论文，之前投CCM没中，改投ICM中了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=783, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 28 13:27:00 CST 2010, time=2010-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536175, encodeId=f7bf5361e577, content=不到一周回复，要求改letter, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=614, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Apr 29 17:36:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833359, encodeId=729183335951, content=让我转投springerplus，什么鬼？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Tue Aug 23 10:30:55 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523505, encodeId=4fe352350512, content=10.125。我的天！难怪三天就把我拒了，要我转投springerplus。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue Jun 14 11:10:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510327, encodeId=438a51032ea9, content=祝贺！匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, beContent=匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=763, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Mar 09 12:04:00 CST 2015, time=2015-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487171, encodeId=a1a548e17175, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一个月审稿，小修后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=665, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 09 00:27:00 CST 2012, time=2012-03-09, status=1, ipAttribution=)]

2024-08-09 ms8000001161552998 来自黑龙江省

审稿速度:1.0
经验分享：投了一篇Corrrspondence，修稿2次，2个半月接收

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2219282, encodeId=846f221928247, content=审稿速度:1.0 经验分享：投了一篇Corrrspondence，修稿2次，2个半月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Fri Aug 09 16:30:53 CST 2024, time=2024-08-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=578810, encodeId=54dd5e881084, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589199, encodeId=a19c589199f6, content=请问这个杂志好投吗？medcardio 2015-03-09 12:04:00 发表: 祝贺！, beContent=medcardio 2015-03-09 12:04:00 发表: 祝贺！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70791714941, createdName=执着与奋斗, createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470172, encodeId=f3d64e0172ab, content=重视偏重系列研究的论文，之前投CCM没中，改投ICM中了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=783, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 28 13:27:00 CST 2010, time=2010-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536175, encodeId=f7bf5361e577, content=不到一周回复，要求改letter, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=614, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Apr 29 17:36:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833359, encodeId=729183335951, content=让我转投springerplus，什么鬼？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Tue Aug 23 10:30:55 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523505, encodeId=4fe352350512, content=10.125。我的天！难怪三天就把我拒了，要我转投springerplus。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue Jun 14 11:10:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510327, encodeId=438a51032ea9, content=祝贺！匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, beContent=匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=763, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Mar 09 12:04:00 CST 2015, time=2015-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487171, encodeId=a1a548e17175, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一个月审稿，小修后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=665, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 09 00:27:00 CST 2012, time=2012-03-09, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

审稿时间有点长

575 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219282, encodeId=846f221928247, content=审稿速度:1.0 经验分享：投了一篇Corrrspondence，修稿2次，2个半月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Fri Aug 09 16:30:53 CST 2024, time=2024-08-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=578810, encodeId=54dd5e881084, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589199, encodeId=a19c589199f6, content=请问这个杂志好投吗？medcardio 2015-03-09 12:04:00 发表: 祝贺！, beContent=medcardio 2015-03-09 12:04:00 发表: 祝贺！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70791714941, createdName=执着与奋斗, createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470172, encodeId=f3d64e0172ab, content=重视偏重系列研究的论文，之前投CCM没中，改投ICM中了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=783, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 28 13:27:00 CST 2010, time=2010-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536175, encodeId=f7bf5361e577, content=不到一周回复，要求改letter, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=614, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Apr 29 17:36:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833359, encodeId=729183335951, content=让我转投springerplus，什么鬼？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Tue Aug 23 10:30:55 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523505, encodeId=4fe352350512, content=10.125。我的天！难怪三天就把我拒了，要我转投springerplus。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue Jun 14 11:10:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510327, encodeId=438a51032ea9, content=祝贺！匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, beContent=匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=763, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Mar 09 12:04:00 CST 2015, time=2015-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487171, encodeId=a1a548e17175, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一个月审稿，小修后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=665, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 09 00:27:00 CST 2012, time=2012-03-09, status=1, ipAttribution=)]

2020-04-18 执着与奋斗

请问这个杂志好投吗？medcardio 2015-03-09 12:04:00 发表:
祝贺！

medcardio 2015-03-09 12:04:00 发表: 祝贺！

408 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219282, encodeId=846f221928247, content=审稿速度:1.0 经验分享：投了一篇Corrrspondence，修稿2次，2个半月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Fri Aug 09 16:30:53 CST 2024, time=2024-08-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=578810, encodeId=54dd5e881084, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589199, encodeId=a19c589199f6, content=请问这个杂志好投吗？medcardio 2015-03-09 12:04:00 发表: 祝贺！, beContent=medcardio 2015-03-09 12:04:00 发表: 祝贺！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70791714941, createdName=执着与奋斗, createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470172, encodeId=f3d64e0172ab, content=重视偏重系列研究的论文，之前投CCM没中，改投ICM中了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=783, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 28 13:27:00 CST 2010, time=2010-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536175, encodeId=f7bf5361e577, content=不到一周回复，要求改letter, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=614, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Apr 29 17:36:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833359, encodeId=729183335951, content=让我转投springerplus，什么鬼？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Tue Aug 23 10:30:55 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523505, encodeId=4fe352350512, content=10.125。我的天！难怪三天就把我拒了，要我转投springerplus。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue Jun 14 11:10:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510327, encodeId=438a51032ea9, content=祝贺！匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, beContent=匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=763, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Mar 09 12:04:00 CST 2015, time=2015-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487171, encodeId=a1a548e17175, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一个月审稿，小修后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=665, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 09 00:27:00 CST 2012, time=2012-03-09, status=1, ipAttribution=)]

2010-01-28 匿名用户

重视偏重系列研究的论文，之前投CCM没中，改投ICM中了。

783 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219282, encodeId=846f221928247, content=审稿速度:1.0 经验分享：投了一篇Corrrspondence，修稿2次，2个半月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Fri Aug 09 16:30:53 CST 2024, time=2024-08-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=578810, encodeId=54dd5e881084, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589199, encodeId=a19c589199f6, content=请问这个杂志好投吗？medcardio 2015-03-09 12:04:00 发表: 祝贺！, beContent=medcardio 2015-03-09 12:04:00 发表: 祝贺！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70791714941, createdName=执着与奋斗, createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470172, encodeId=f3d64e0172ab, content=重视偏重系列研究的论文，之前投CCM没中，改投ICM中了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=783, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 28 13:27:00 CST 2010, time=2010-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536175, encodeId=f7bf5361e577, content=不到一周回复，要求改letter, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=614, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Apr 29 17:36:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833359, encodeId=729183335951, content=让我转投springerplus，什么鬼？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Tue Aug 23 10:30:55 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523505, encodeId=4fe352350512, content=10.125。我的天！难怪三天就把我拒了，要我转投springerplus。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue Jun 14 11:10:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510327, encodeId=438a51032ea9, content=祝贺！匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, beContent=匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=763, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Mar 09 12:04:00 CST 2015, time=2015-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487171, encodeId=a1a548e17175, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一个月审稿，小修后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=665, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 09 00:27:00 CST 2012, time=2012-03-09, status=1, ipAttribution=)]

2017-04-29 chen13

不到一周回复，要求改letter

614 0

[GetPortalCommentsPageByObjectIdResponse(id=2219282, encodeId=846f221928247, content=审稿速度:1.0 经验分享：投了一篇Corrrspondence，修稿2次，2个半月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Fri Aug 09 16:30:53 CST 2024, time=2024-08-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=578810, encodeId=54dd5e881084, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589199, encodeId=a19c589199f6, content=请问这个杂志好投吗？medcardio 2015-03-09 12:04:00 发表: 祝贺！, beContent=medcardio 2015-03-09 12:04:00 发表: 祝贺！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70791714941, createdName=执着与奋斗, createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470172, encodeId=f3d64e0172ab, content=重视偏重系列研究的论文，之前投CCM没中，改投ICM中了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=783, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 28 13:27:00 CST 2010, time=2010-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536175, encodeId=f7bf5361e577, content=不到一周回复，要求改letter, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=614, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Apr 29 17:36:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833359, encodeId=729183335951, content=让我转投springerplus，什么鬼？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Tue Aug 23 10:30:55 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523505, encodeId=4fe352350512, content=10.125。我的天！难怪三天就把我拒了，要我转投springerplus。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue Jun 14 11:10:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510327, encodeId=438a51032ea9, content=祝贺！匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, beContent=匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=763, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Mar 09 12:04:00 CST 2015, time=2015-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487171, encodeId=a1a548e17175, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一个月审稿，小修后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=665, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 09 00:27:00 CST 2012, time=2012-03-09, status=1, ipAttribution=)]

2016-08-23 ms6967342940128728

让我转投springerplus，什么鬼？

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2219282, encodeId=846f221928247, content=审稿速度:1.0 经验分享：投了一篇Corrrspondence，修稿2次，2个半月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Fri Aug 09 16:30:53 CST 2024, time=2024-08-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=578810, encodeId=54dd5e881084, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589199, encodeId=a19c589199f6, content=请问这个杂志好投吗？medcardio 2015-03-09 12:04:00 发表: 祝贺！, beContent=medcardio 2015-03-09 12:04:00 发表: 祝贺！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70791714941, createdName=执着与奋斗, createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470172, encodeId=f3d64e0172ab, content=重视偏重系列研究的论文，之前投CCM没中，改投ICM中了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=783, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 28 13:27:00 CST 2010, time=2010-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536175, encodeId=f7bf5361e577, content=不到一周回复，要求改letter, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=614, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Apr 29 17:36:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833359, encodeId=729183335951, content=让我转投springerplus，什么鬼？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Tue Aug 23 10:30:55 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523505, encodeId=4fe352350512, content=10.125。我的天！难怪三天就把我拒了，要我转投springerplus。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue Jun 14 11:10:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510327, encodeId=438a51032ea9, content=祝贺！匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, beContent=匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=763, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Mar 09 12:04:00 CST 2015, time=2015-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487171, encodeId=a1a548e17175, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一个月审稿，小修后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=665, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 09 00:27:00 CST 2012, time=2012-03-09, status=1, ipAttribution=)]

2016-06-14 maomao0807

10.125。我的天！难怪三天就把我拒了，要我转投springerplus。

641 0

[GetPortalCommentsPageByObjectIdResponse(id=2219282, encodeId=846f221928247, content=审稿速度:1.0 经验分享：投了一篇Corrrspondence，修稿2次，2个半月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Fri Aug 09 16:30:53 CST 2024, time=2024-08-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=578810, encodeId=54dd5e881084, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589199, encodeId=a19c589199f6, content=请问这个杂志好投吗？medcardio 2015-03-09 12:04:00 发表: 祝贺！, beContent=medcardio 2015-03-09 12:04:00 发表: 祝贺！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70791714941, createdName=执着与奋斗, createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470172, encodeId=f3d64e0172ab, content=重视偏重系列研究的论文，之前投CCM没中，改投ICM中了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=783, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 28 13:27:00 CST 2010, time=2010-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536175, encodeId=f7bf5361e577, content=不到一周回复，要求改letter, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=614, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Apr 29 17:36:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833359, encodeId=729183335951, content=让我转投springerplus，什么鬼？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Tue Aug 23 10:30:55 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523505, encodeId=4fe352350512, content=10.125。我的天！难怪三天就把我拒了，要我转投springerplus。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue Jun 14 11:10:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510327, encodeId=438a51032ea9, content=祝贺！匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, beContent=匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=763, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Mar 09 12:04:00 CST 2015, time=2015-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487171, encodeId=a1a548e17175, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一个月审稿，小修后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=665, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 09 00:27:00 CST 2012, time=2012-03-09, status=1, ipAttribution=)]

2015-03-09 medcardio

祝贺！匿名 2012-03-09 发表::
接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。

匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。

763 0

[GetPortalCommentsPageByObjectIdResponse(id=2219282, encodeId=846f221928247, content=审稿速度:1.0 经验分享：投了一篇Corrrspondence，修稿2次，2个半月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Fri Aug 09 16:30:53 CST 2024, time=2024-08-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=578810, encodeId=54dd5e881084, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589199, encodeId=a19c589199f6, content=请问这个杂志好投吗？medcardio 2015-03-09 12:04:00 发表: 祝贺！, beContent=medcardio 2015-03-09 12:04:00 发表: 祝贺！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70791714941, createdName=执着与奋斗, createdTime=Sat Apr 18 00:00:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470172, encodeId=f3d64e0172ab, content=重视偏重系列研究的论文，之前投CCM没中，改投ICM中了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=783, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 28 13:27:00 CST 2010, time=2010-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536175, encodeId=f7bf5361e577, content=不到一周回复，要求改letter, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=614, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Apr 29 17:36:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833359, encodeId=729183335951, content=让我转投springerplus，什么鬼？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Tue Aug 23 10:30:55 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523505, encodeId=4fe352350512, content=10.125。我的天！难怪三天就把我拒了，要我转投springerplus。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue Jun 14 11:10:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510327, encodeId=438a51032ea9, content=祝贺！匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, beContent=匿名 2012-03-09 发表:: 接收率：约50% 审稿时间：约1个月一个月审稿，小修后接受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=763, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Mar 09 12:04:00 CST 2015, time=2015-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487171, encodeId=a1a548e17175, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一个月审稿，小修后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=665, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 09 00:27:00 CST 2012, time=2012-03-09, status=1, ipAttribution=)]

2012-03-09 匿名用户

审稿速度:1.0 | 投稿命中率:50.0
经验分享：一个月审稿，小修后接受。

665 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务